Publication Date
In 2025 | 0 |
Since 2024 | 0 |
Since 2021 (last 5 years) | 0 |
Since 2016 (last 10 years) | 2 |
Since 2006 (last 20 years) | 2 |
Descriptor
Data Analysis | 2 |
Meta Analysis | 2 |
Models | 2 |
Network Analysis | 2 |
Accuracy | 1 |
Bayesian Statistics | 1 |
Cancer | 1 |
Comparative Analysis | 1 |
Data | 1 |
Diseases | 1 |
Drug Therapy | 1 |
More ▼ |
Source
Research Synthesis Methods | 2 |
Author
Afdhal, Nezam | 1 |
Carpenter, James R. | 1 |
Freeman, Suzanne C. | 1 |
Gray, Emma | 1 |
Leahy, Joy | 1 |
Milligan, Scott | 1 |
O'Leary, Aisling | 1 |
Walsh, Cathal | 1 |
Wehmeyer, Malte H. | 1 |
Publication Type
Journal Articles | 2 |
Reports - Research | 2 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Freeman, Suzanne C.; Carpenter, James R. – Research Synthesis Methods, 2017
Network meta-analysis (NMA) combines direct and indirect evidence from trials to calculate and rank treatment estimates. While modelling approaches for continuous and binary outcomes are relatively well developed, less work has been done with time-to-event outcomes. Such outcomes are usually analysed using Cox proportional hazard (PH) models.…
Descriptors: Bayesian Statistics, Network Analysis, Meta Analysis, Data
Leahy, Joy; O'Leary, Aisling; Afdhal, Nezam; Gray, Emma; Milligan, Scott; Wehmeyer, Malte H.; Walsh, Cathal – Research Synthesis Methods, 2018
The use of individual patient data (IPD) in network meta-analysis (NMA) is becoming increasingly popular. However, as most studies do not report IPD, most NMAs are performed using aggregate data for at least some, if not all, of the studies. We investigate the benefits of including varying proportions of IPD studies in an NMA. Several models have…
Descriptors: Patients, Medical Research, Meta Analysis, Network Analysis